2160 studies found for:    Open Studies | "Drug Therapy"
Show Display Options
Rank Status Study
21 Recruiting Nutrition Intervention During Chemotherapy
Condition: Cancer Patients Receiving Chemotherapy or Chemoradiotherapy
Intervention: Dietary Supplement: Daily intake for 10 weeks (+/- 2 weeks)
22 Unknown  Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34
23 Recruiting Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
Condition: Antineoplastic Chemotherapy Induced Anemia
Intervention: Biological: Epoetin alfa
24 Recruiting Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Conditions: Castrate Resistant Prostate Cancer;   Chemotherapy Naive Prostate Cancer;   Prostate Cancer
Interventions: Drug: Pasireotide;   Drug: Everolimus;   Other: Laboratory biomarker analysis
25 Not yet recruiting Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Conditions: Breast Cancer;   Chemotherapy Induced Amenorrhea;   Ovarian Function Suppression
Interventions: Drug: Goserelin;   Drug: Toremifene
26 Recruiting Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031 AM4)
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy
27 Recruiting A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Conditions: Taxane-induced Peripheral Neuropathy;   Chemotherapy-induced Peripheral Neuropathy (CIPN);   Early-Stage Breast Carcinoma;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Procedure: Immediate Acupuncture Group;   Procedure: Delayed Acupuncture Group
28 Recruiting Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029)
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant 150 mg;   Drug: Fosaprepitant 60 mg;   Drug: Fosaprepitant 20 mg;   Drug: Placebo Fosaprepitant;   Drug: Ondansetron
29 Recruiting Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Condition: Metastatic Breast Cancer Starting a Third Line Chemotherapy
Intervention: Other: Construction of a prognostic score (non-drug intervention types)
30 Unknown  Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
Conditions: Advanced Metastastic Malignant Melanoma;   Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Intervention: Device: hyperthermia
31 Not yet recruiting Early Jejunostomy Nutrition Minimizes Time to Chemotherapy
Conditions: Gastric Cancer;   Laparoscopic Surgery;   Chemotherapy
Interventions: Procedure: Jejunostomy;   Other: Early oral nutrition
32 Recruiting Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
Conditions: Anorexia;   Cachexia;   Malignant Neoplasm;   Oral Complications of Chemotherapy
Interventions: Biological: bovine lactoferrin supplement;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
33 Recruiting A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Dexamethasone 12 mg IV;   Drug: fosaprepitant 150 mg IV
34 Recruiting Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
Conditions: Gastrointestinal Cancer;   Nausea Post Chemotherapy
Intervention: Drug: fosaprepitant dimeglumine
35 Recruiting Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer
Condition: Advanced Gastric Cancer With Serosal Invasion
Interventions: Procedure: surgery;   Drug: adjuvant systemic chemotherapy;   Drug: Early postoperative intraperitoneal chemothgerapy
36 Recruiting Medication Therapy Management With Pharmacogenetic Testing
Conditions: Pharmacogenetics;   Medication Therapy Management
Intervention: Other: MTM with PGx
37 Recruiting DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
Conditions: Fasting Mimicking Diet;   Breast Cancer;   Neoadjuvant Chemotherapy;   Pathological Complete Response
Intervention: Other: Fasting mimicking diet
38 Recruiting Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy
Conditions: Colorectal Cancer;   Dysgeusia;   Oral Complications of Chemotherapy
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Biological: bovine lactoferrin
39 Recruiting Acupuncture for Chemotherapy-induced Peripheral Neuropathy
Conditions: Peripheral Neuropathy;   Toxicity Due to Chemotherapy;   Lymphoma;   Multiple Myeloma
Intervention: Procedure: Acupuncture
40 Unknown  Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer
Conditions: Adjuvant Chemotherapy;   Colon Cancer;   Immunity
Interventions: Dietary Supplement: zinc;   Other: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years